MedTrace Logo

Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients

NCT00652678 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2021-10-22

No results posted yet for this study

Summary

Some patients who undergo breast cancer treatment with lumpectomy followed by radiation therapy develop significant late skin and soft tissue changes, resulting in a poor cosmetic outcome. The goal of this study is to try to predict severe tissue reactions by using a combination of three of the latest blood tests, one of which we have developed ourselves.

Conditions

  • Abnormalities, Radiation-Induced

Sponsors & Collaborators

  • Carol M. Baldwin Breast Cancer Research Fund, Inc.

    collaborator OTHER

  • State University of New York - Upstate Medical University

    lead OTHER

Principal Investigators

  • Peter J Hahn, PhD · State University of New York - Upstate Medical University

Eligibility

Min Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00652678 on ClinicalTrials.gov